University of Maryland School of Medicine

Baltimore, Maryland
Associate Dean of Research, University of Maryland School of Medicine
Director, Center for Stem Cell Biology & Regenerative Medicine

Research

Leukemia is a great success story for cancer research — one in which Dr. Curt Civin played an important role. His early work on bone marrow stem cell transplantation was partially responsible for the dramatic increase of the five-year survival for all types of leukemia over the past 20 years.

Dr. Civin discovered CD34, the first – and still best – marker of hematopoietic (blood-forming) stem cells ever found. His subsequent isolation of CD34+ stem cells opened entirely new approaches to leukemia treatment. The CD34+ transplantation technology, created by a team of scientists in Dr. Civin’s laboratory, has been widely applied and thousands of patients’ lives have been saved because of this approach to treating cancer.

And now, for patients still suffering from certain leukemias that are difficult to treat and waiting for a cure, Dr. Civin’s current research may once again hold the key. Acute myeloid leukemia (AML) is the deadliest form of leukemia, and Dr. Civin recently discovered that artemisinins – a class of drugs with low toxicity used to successfully treat malaria – are also effective in killing AML cancer cells. Through research, he identified ART-838, a specific artemisinin compound that shows remarkable preliminary effectiveness against leukemia cells and works well in combination with established anti-leukemia drugs. In addition, the compound can be given orally and stays active in the bloodstream for a long time. Plus, it doesn’t appear to harm normal bone marrow cells, so it may prove to be an effective new treatment for AML patients.

Years of NFCR support to Dr. Civin’s laboratory efforts have led to promising experimental therapeutic technology now being commercialized through the AIM-HI Translational Research Initiative. To learn more, click here.

Bio

Curt Civin, M.D., is the Associate Dean for Research and the Founding Director of the Center for Stem Cell Biology and Regenerative Medicine at the University of Maryland School of Medicine. Dr. Civin graduated from Amherst College in 1970 before attending Harvard Medical School and completing fellowships in pediatric oncology with the National Cancer Institute.

Prior to joining the University of Maryland’s faculty, Dr. Civin spent 30 years at Johns Hopkins School of Medicine leading research and clinical pediatric oncology.

In addition to holding 21 biomedical patents, Dr. Civin’s 1984 discovery of CD34 earned him the National Inventor of the Year Award in 1999.He has lectured around the world, published more than 250 articles and book chapters, received many awards, and served in leadership positions of multiple distinguished committees and editorial boards. Throughout his career, he has mentored a large number of talented scientists to pursue field-leading academic careers in translational research.

Curt Civin

Areas of Focus

Cancer Types

Years of NFCR Funding

1997 – Present

Related Content

An Unexpected Opportunity: Erin’s Story

7 Facts You Need to Know About Blood Cancers

Multiple Myeloma: A Rare But Very Real Cancer

On May 23, 2018, my mother, Susan Williams, was admitted to UNC Rex Hospital in our home town of Raleigh, North Carolina, after being told that some “abnormalities” had shown up in her blood test. Several months earlier, my mom experienced excruciating pain around her rib cage and back that caused her to eventually become immobile. She met with multiple specialists to get opinions on what might be wrong. She was told it was probably a pulled muscle, maybe potential nerve damage, even osteoporosis. That is when we finally found out she had several fractures in her ribs, pelvis, and multiple crushed vertebrae. This explained the pain she endured. However, It wasn’t until that day in May when we finally got the answer we had been waiting for. The dreadful diagnosis that would change our family and, more greatly, my mom’s life forever. Multiple Myeloma is a cancer of the plasma cells which are white blood cells that help fight infection and are made in the bone marrow. The more of these cells that have myeloma, the more severe the symptoms are for patients; such as weak bones and a higher risk of infection— which often is what will lead to their demise. There is currently no cure for Multiple Myeloma. There are standard treatment options available to help manage the progression. A common treatment is a Stem Cell Transplant or Bone Marrow Transplant, where patients are dosed with intense chemotherapy that will hopefully kill the myeloma cells and replace enough of them with healthy cells. The majority of Myeloma patients will only need to have this transplant once. My mother was an exception. She had to go through it twice. After transplant, patients will often try different maintenance chemotherapies until one keeps their myeloma cell counts low and manageable. Multiple Myeloma never reaches remission because the disease is always in the blood and most likely will come back. Again, there is no cure. Learn more about Multiple Myeloma on NFCR’s blog here. Spreading awareness about this disease is crucial because it is difficult to diagnose correctly let alone detect early. It is also hard to track how well patients will respond to treatments and if treatment will even work at all, which is a discouraging fate my mom has been faced with. There are still a lot of unknowns about this cancer and we need to support research to be able to answer those questions. Every day we constantly prepare for the worst. Our hope is that my mom will be able to see the day when advancements in cancer research will save her life. March is Multiple Myeloma Awareness Month and I truly believe that awareness may help bring a cure someday.  It’s heartbreaking seeing someone you love suffer every day. We are faced with overwhelming feelings of helplessness when we can’t take their pain away. I wanted to do something more to help my mom which is what motivated me to volunteer my time to help the National Foundation for Cancer Research (NFCR) and their mission – Research for a Cure. Everyone has something to give to […]